Who Paid My Doc
Stephen Hindman
Cardiovascular Disease Jackson, MS Medical Doctor
NPI 1508885435 CMS profile 113435
501 Marshall St Ste 104, Jackson, MS 39202
General payments
$2,626
Research payments
$0
Ownership & investment interest
$0
Through program year 2023, Stephen Hindman of Jackson, MS is reported in the CMS Open Payments database as having received $2,626 across 137 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 55th percentile of Cardiovascular Disease profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
5 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $78 | 5 | |
| 2022 | General | $253 | 15 | |
| 2021 | General | $270 | 14 | |
| 2020 | General | $607 | 32 | |
| 2019 | General | $1,417 | 71 |
Beside peers
- Stephen Hindman
- Cardiovascular Disease median
- Middle half of Cardiovascular Disease
- National median
In program year 2025, general payments to Stephen Hindman were reported at $0. Among 16,617 Cardiovascular Disease profiles paid that year, the median was $432 and the middle half received between $132 and $1,252.
Show as a table
| Year | Stephen Hindman | Cardiovascular Disease median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $1,417 | $450 | $127–$1,392 | $163 |
| 2020 | $607 | $242 | $77–$751 | $114 |
| 2021 | $270 | $335 | $101–$1,037 | $132 |
| 2022 | $253 | $395 | $121–$1,211 | $149 |
| 2023 | $78 | $443 | $136–$1,283 | $160 |
| 2024 | $0 | $450 | $136–$1,323 | $164 |
| 2025 | $0 | $432 | $132–$1,252 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 16 drugsPart D claims
471
Drug cost
$66,031
Branded share of claims
33.3%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Xarelto Rivaroxaban | Brand | 63 | $50,377 | |
| Eliquis Apixaban | Brand | 13 | $12,010 | |
| Metoprolol Succinate | Generic | 32 | $548 | |
| Spironolactone | Generic | 54 | $537 | |
| Rosuvastatin Calcium | Generic | 43 | $470 | |
| Atorvastatin Calcium | Generic | 33 | $313 | |
| Olmesartan-Hydrochlorothiazide Olmesartan/Hydrochlorothiazide | Brand | 15 | $241 | |
| Furosemide | Generic | 49 | $236 | |
| Sotalol Sotalol Hcl | Brand | 19 | $232 | |
| Diltiazem 24hr Er (Cd) Diltiazem Hcl | Brand | 18 | $199 |
The 10 drugs with the highest cost, of 16 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 104,182 Part D prescribers listed as Internal Medicine; they describe a distribution and say nothing about conduct.
Records
137 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Cardiovascular Disease in Mississippi
Dharmesh Patel
Cardiovascular Disease · Southaven, MS
Barry Bertolet
Cardiovascular Disease · Tupelo, MS
Donny Stokes
Cardiovascular Disease · Jackson, MS
Mahmoud Zayed
Cardiovascular Disease · Pascagoula, MS
James Bensler
Cardiovascular Disease · Jackson, MS
Michael Hall
Cardiovascular Disease · Jackson, MS
Related records
Cardiovascular Disease in Mississippi
Practitioners in the same specialty and state, ranked by reported value.
All Cardiovascular Disease
Everyone recorded under this specialty, nationwide.
Doctors in Mississippi
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.